Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.21.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2019 $ 8,016 $ 26,259,576 $ (18,495,462) $ (317,698) $ 7,454,432
Balance, shares at Dec. 31, 2019 8,015,756        
Issuance of common stock to noteholders   $ 160 201,164 201,324
Issuance of common stock to noteholders, shares   160,000        
Returned common stock from noteholder   $ (153) 153
Returned common stock from noteholder, shares   (153,005)        
Issuance of common stock to consultants   $ 654 562,109 562,763
Issuance of common stock to consultants, shares   653,750        
Issuance of warrants to noteholders and beneficial conversion options   1,018,953 1,018,953
Stock-based compensation   748,749 748,749
Divestiture of Cloud B         (26,392) (26,392)
Net income loss   1,269,492 (3,397,975)
Balance at Mar. 31, 2020 $ 8,677 28,790,704 (17,225,970) (344,090) 11,229,321
Balance, shares at Mar. 31, 2020 8,676,501        
Balance at Dec. 31, 2020 $ 765 $ 14,471 39,050,260 (23,648,898) (1,893,897) 13,522,701
Balance, shares at Dec. 31, 2020 764,618 14,471,403        
Issuance of common stock to noteholders   $ 5,878 11,510,814 11,516,692
Issuance of common stock to noteholders, shares   5,877,908        
Returned common stock from noteholder   $ (153) 153
Returned common stock from noteholder, shares   (153,005)        
Issuance of common stock to investors   $ 1,500 3,253,500 3,255,000
Issuance of common stock to investors, shares   1,500,000        
Issuance of common stock to consultants   $ 943 2,035,392 2,036,335
Issuance of common stock to consultants, shares   943,000        
Issuance of common stock to employees   $ 1,263 3,290,927     3,292,190
Issuance of common stock to employees, shares   1,262,872        
Issuance of warrants to noteholders and beneficial conversion options 19,720,000 19,720,000
Issuance of common stock upon exercise of warrants $ 881 1,689,723 1,690,604
Issuance of common stock upon exercise of warrants, shares 880,798        
Conversions under notes payable   $ 5,574 11,088,446 11,094,020
Conversions under notes payable, shares   5,574,425        
Exercise of warrant liabilities   259,427 259,427
Stock-based compensation   3,660,436 3,660,436
Issuance of common stock acquisitions   $ 750 1,251,750 1,252,500
Issuance of common stock acquisitions, shares   750,000        
Net income loss   (62,469,554) 28,034 (62,263,320)
Balance at Mar. 31, 2021 $ 765 $ 25,686 $ 66,002,229 $ (86,118,452) $ (1,865,863) $ (21,955,635)
Balance, shares at Mar. 31, 2021 764,618 25,685,981